Hilden, Germany, and Germantown, Maryland, February 11, 2016 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced the introduction of more than 170 new QIAseq Targeted RNA Panels for gene expression profiling, expanding QIAGEN’s portfolio of Sample to Insight solutions for next-generation sequencing (NGS). The panels enable researchers to select from over 20,000 human […]

LONDON & SAN DIEGO – Illumina, Inc. (NASDAQ: ILMN) and Genomics England today announce a partnership to develop a platform and knowledge base that can be used to improve and automate genome interpretation. The tools will operate within the Genomics England secure database to enable researchers and clinicians to access information and reports more readily. […]

ORLANDO, Fla., — Silicon Biosystems Menarini Inc., a developer and manufac­turer of technologies and products that help uncover the biological complexities of disease at the single-cell level, and Swift Biosciences Inc., a developer of innovative technologies for genomics research, announced a scientific collaboration and co-marketing partnership aimed at enabling translational researchers to obtain high-quality sequencing […]

SAN DIEGO – Illumina, Inc. (NASDAQ: ILMN) announced it is building partnerships to enable long read applications. In support of the partnership ecosystem, Illumina announced the signing of a co-marketing agreement to promote 10x Genomics Linked-Read sequencing products and Illumina sequencing systems. Illumina is building long read application partnerships that will enable customers to more […]

SAN DIEGO – Illumina, Inc. (NASDAQ: ILMN) announced it is building partnerships to enable long read applications. In support of the partnership ecosystem, Illumina announced the signing of a co-marketing agreement to promote 10x Genomics Linked-Read sequencing products and Illumina sequencing systems. Illumina is building long read application partnerships that will enable customers to more […]

SANTA CRUZ, Calif.,- Somagenics has been awarded a second phase I SBIR grant from NIH to develop its resQ-RNATM technology for quantitative real-time PCR of fragmented RNA samples. Fragmentation of RNA is a particular problem in tissue samples that have been preserved and stored (e.g., formaldehyde-fixed, paraffin-embedded [FFPE] specimens) or collected under sub-optimal conditions (forensic […]

Orlando, Florida, February 9, 2016 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced a collaboration with 10x Genomics to develop and promote comprehensive solutions for next-generation sequencing (NGS), single-cell biology and bioinformatics. This collaboration includes: Optimizing QIAGEN’s sample technologies for use with 10x Genomics GemCode and Chromium systems. This includes QIAGEN’s MagAttract HMW […]

SCHLIEREN, Switzerland, – The Volpi Group, a 60-year-old optical electronics firm based in Schlieren, Switzerland, announced that it is collaborating with QIAGEN Instruments AG on the manufacture of the automated fluorescence imaging module used in QIAGEN’s GeneReaderTM next-generation sequencing (NGS) instrument. The benchtop GeneReader combines with other QIAGEN NGS products to provide the first seamless, […]

Ann Arbor, MI – Rubicon Genomics, Inc. announced a new agreement with Beckman Coulter Life Sciences for distribution of its ThruPLEX® Plasma-seq kits for research applications. ThruPLEX Plasma-seq prepares DNA next-generation sequencing (NGS) libraries for the analysis of cell-free DNA circulating in plasma. The non-exclusive agreement covers the U.S. and Canada. It follows an announcement […]